industry
Healthcare & Life Sciences

Equipping a pharmaceutical device carve-out with a finance function

Key technology:
  • New ERP system​​​​​​​​​​
Value levers pulled:
  • Carve-out planning & execution
  • Finance function assessment and design
  • 13-Week cash flow forecasting​​​​

Picture this...

You’re a $400 million pharmaceutical medical device business in the US and UK. You’re being carved-out from a $30 billion Global 100 business that won’t provide direct access to transferring employees, creating unique challenges. You need leadership overseeing the transition management office and a finance and accounting team who can set up the new finance function ERP, payroll systems, organization design, and 13-week cash flow forecasting.

You turn to Accordion.

We lead the executive team, functional leads, and network of advisors to create, execute, and track detailed separation plans Day 1 readiness. To do this we:

  • Ensure all stakeholders maintain business continuity through the ERP transition with planning for future-state F&A and IT enterprise architecture.
  • Identify required regulatory licenses, negotiate additional items to the TSA, gather information from seller to complete license applications, and ensure timely submission of applications to obtain licenses prior to close.
  • Stand up a new accounting function including designing the organization, hiring, creating a delegation of authority matrix, opening bank accounts, and getting T&E and payroll systems ready for Day 1.

Your value is enhanced.

Your newly formed company has successfully stood-up independent functions and key processes on Day 1, with full business continuity.

Enhanced value:

You reap multiple benefits, including:

  • New ERP system​​​​​​​​​​​